Archives for April 2007
Product Placement Produces High ROI
Small medical device firms don’t spend much time worrying about advertising. When working within tight budget constraints, a 30-second spot is a luxury most emerging firms can’t afford. But product placement may be an opportunity for smaller companies to get their products in front of a consumer audience – without breaking the bank.
Washington CEO magazine today has an […]
Accuray and CyberHeart Cut a Deal
Accuray, of Sunnyvale, CA, and Menlo Park, CA-based CyberHeart have inked a deal by which CyberHeart will use Accuray’s technology to develop a non-invasive method for performing cardiac ablation. Long-term visions for the developed technology also include applications to treat atrial fibrillation.
Cardiac ablation, used to destroy a small portion of the heart that is causing […]
Greatbatch to Buy Enpath for $102 Million
Greatbatch, of Clarence, NY, said today that it would acquire Minneapolis-based Enpath Medical for $102 million. The purchase, which includes assumption of debt (about $5.5 million worth, according to the Associate Press), gives Greatbatch an increased presence in the cardiac rhythm management and neurostimulation markets.
Enpath’s main product lines include the following: Venous vessel introducers and valved introducers […]
NFL Stars Back New Supplement Delivery System
HealthSport, an Amherst, NY-based company that makes an edible film strip delivery system for nutritional supplements, has raised $3 million in a private placement. The money, part of which came from three National Football League stars turned investors — Bruce Smith and Jim Kelly, formerly of the Buffalo Bills, and Bernie Kosar, an ex-Cleveland Brown […]
New Eye Mask for Growing Blepharoplasty Market
BioElectronics Corporation, a Frederick, MD-based company that makes anti-inflammatory patches to accelerate healing after surgery, has come out with a new eye mask to hold in place its ActiPatch therapy on patients who have had eyelid surgery. The mask, made of a soft, breathable fabric, has a pocket on each side that holds a crescent shaped […]
Coherex Closing in on NMT and AGA in PFO Market
Red Herring yesterday ran an article about a three-way race to develop an FDA-approved PFO closure device. In the running are Coherex Medical, NMT Medical and AGA Medical. A PFO, or patent foramen ovale, is an opening in the upper chambers of the heart. All infants are born with foramen ovales, but the opening is supposed to […]
Westaim Management to Look at ‘Strategic Alternatives’
Reeling from its weakened share price, Westaim Corporation, a Canadian company that makes wound care and pharmaceutical products from nanotechnology, is taking a closer look at its business strategy. In light of unimpressive stock performance — Westaim has been trading at less than $1, down from more than $5 one year ago — the company’s board has directed management to come up […]
High Hopes for New Prostate-Cancer Test
Results released today from a study of a new test for prostate cancer have raised spirits in the medical community and at the private Seattle firm that discovered it.
Onconome’s blood test measures EPCA-2 (Early Prostate Cancer Antigen), a newly discovered blood protein that when elevated, appears to indicate the presence of prostate cancer. In this latest study, […]
AFP Captures Italian Firm’s 3-D Imaging Device
AFP Imaging Corporation, of Elmsford, NY, has successfully completed the acquisition of Quantitative Radiology (QR), an Italian firm for which AFP has been the exclusive North American distributor for the past year. Most notably, with the acquisition comes QR’s principal product, a digital x-ray device that builds three dimensional images from captured data. Primary users of […]
Yulex Expands Beyond Surgical Gloves
The latest issue of Fast Company has a profile of Yulex Corporation, a Carlsbad, CA, company known for making latex products that are safe for people with tropical latex allergies. Since being founded in 1997, the company’s bread and butter has been surgical gloves and condoms. But, the firm is now using its version of latex, dervied from […]
